New kits are designed to offer a convenient method to label any antibody with one of Bio-Rad’s StarBright Dyes.

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

Medically reviewed by Robert Burakoff, MD Irritable bowel syndrome (IBS) is a combination of digestive symptoms, including ...

TAT and several other markers demonstrated an ability to predict the development of venous thromboembolism in patients with cervical cancer.

At-home rapid tests for COVID-19 and influenza are becoming available, allowing simultaneous diagnosis, which aids timely and effective treatment and improves patient outcomes.

From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

Sanofi-backed Abcuro has secured $200 million in series C funds to power its anti-KLRG1 antibody through a phase 2/3 muscle ...